Skip to main content
logo
Merck & Co., Inc. (MRK)
NYSE: MRK · Real-Time Price · USD
150.94
+0.58 (0.39%)
Nov 5, 2026, 11:16 AM EST - Market open

Revenue

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16 Dec '15 Dec '14 Dec '13 Dec '12
Keytruda/Keytruda Qlex Revenue
33.37B31.68B29.48B
Gardasil/Gardasil 9 Revenue
5.26B5.23B8.58B
Januvia/Janumet Revenue
1.88B2.54B2.27B
ProQuad/M-M-R II/Varivax Revenue
2.48B2.45B2.49B
Bridion Revenue
1.61B1.84B1.76B
Lynparza - Alliance Revenue
1.45B1.45B1.31B
Winrevair Revenue
2.27B1.44B419.00M
Lenvima - Alliance Revenue
1.10B1.05B1.01B
Pharmaceutical Revenue
60.22B58.14B57.40B
Animal Health Revenue
6.75B6.35B5.88B
Other Product Revenue
411.00M515.00M891.00M
Revenue (Other)
-49.43B-47.70B-47.32B
Revenue (Total)
67.38B65.01B64.17B

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16 Dec '15 Dec '14 Dec '13 Dec '12
United States Revenue
-36.51B32.28B
Europe, Middle East and Africa Revenue
-14.58B14.04B
Latin America Revenue
-3.41B3.46B
China Revenue
-1.94B5.49B
Asia Pacific (other than China and Japan) Revenue
-2.98B3.06B
Japan Revenue
-2.71B3.28B
Other Geographic Revenue
-2.88B2.56B
Revenue (Total)
67.38B65.01B64.17B

EBT

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16 Dec '15 Dec '14 Dec '13 Dec '12
Pharmaceutical Segment Profit
45.75B44.53B
Animal Health Segment Profit
2.13B1.94B
Other Segment Profit
-26.82B-26.54B